What Researchers Did
Researchers reported on a 27-year-old female with chronic decompression illness cognitive dysfunction who received 58 hyperbaric oxygen treatments.
What They Found
A 27-year-old female developed chronic neurological symptoms, including decreased memory and cognitive function, following altitude chamber training to 25,000 feet. After 58 hyperbaric oxygen treatments, her cognitive function, as measured by Automated Neuropsychological Assessment Metrics, returned to near pre-deployment levels.
What This Means for Canadian Patients
For Canadian patients experiencing chronic cognitive dysfunction following decompression illness, this case suggests that hyperbaric oxygen therapy might be a potential treatment option. Patients should discuss such therapies with their healthcare providers to determine suitability and access.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
As a single case report, the findings are not generalizable to a broader patient population.